178 related articles for article (PubMed ID: 6187426)
1. Treatment of poor prognosis nonseminomatous testicular cancer with a "high-dose" platinum combination chemotherapy regimen.
Ozols RF; Deisseroth AB; Javadpour N; Barlock A; Messerschmidt GL; Young RC
Cancer; 1983 May; 51(10):1803-7. PubMed ID: 6187426
[TBL] [Abstract][Full Text] [Related]
2. Treatment of poor prognosis germ cell tumours with high dose cisplatin regimens.
Ozols RF
Int J Androl; 1987 Feb; 10(1):291-300. PubMed ID: 2438222
[TBL] [Abstract][Full Text] [Related]
3. A randomized trial of standard chemotherapy v a high-dose chemotherapy regimen in the treatment of poor prognosis nonseminomatous germ-cell tumors.
Ozols RF; Ihde DC; Linehan WM; Jacob J; Ostchega Y; Young RC
J Clin Oncol; 1988 Jun; 6(6):1031-40. PubMed ID: 2453619
[TBL] [Abstract][Full Text] [Related]
4. Vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum for advanced germ cell testis tumors: Brazilian experience.
Srougi M; Simon SD; de Góes GM
J Urol; 1985 Jul; 134(1):65-9. PubMed ID: 2409300
[TBL] [Abstract][Full Text] [Related]
5. Tandem high dose chemotherapy with autologous bone marrow transplantation for initial relapse of testicular germ cell cancer.
Broun ER; Nichols CR; Gize G; Cornetta K; Hromas RA; Schacht B; Einhorn LH
Cancer; 1997 Apr; 79(8):1605-10. PubMed ID: 9118046
[TBL] [Abstract][Full Text] [Related]
6. Combination chemotherapy with cis-diammine-dichloro-platinum, vinblastine, and bleomycin in advanced testicular non-seminoma.
Stoter G; Sleijfer DT; Vendrik CP; Schraffordt Koops H; Struyvenberg A; Van Oosterom AT; Brouwers TM; Pinedo HM
Lancet; 1979 May; 1(8123):941-5. PubMed ID: 87614
[TBL] [Abstract][Full Text] [Related]
7. Vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum combination chemotherapy in metastatic testis cancer--a 1-year program.
Vugrin D; Whitmore WF; Golbey RB
J Urol; 1982 Dec; 128(6):1205-8. PubMed ID: 6185697
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of advanced testis cancer with a high dose chemotherapy regimen (PVeBV)].
Kashiwagi A; Nagamori S; Harabayashi T; Shinohara N; Tanaka M; Nonomura K; Koyanagi T
Nihon Hinyokika Gakkai Zasshi; 1996 Jan; 87(1):35-41. PubMed ID: 8683891
[TBL] [Abstract][Full Text] [Related]
9. High-dose cisplatin in hypertonic saline.
Ozols RF; Corden BJ; Jacob J; Wesley MN; Ostchega Y; Young RC
Ann Intern Med; 1984 Jan; 100(1):19-24. PubMed ID: 6197916
[TBL] [Abstract][Full Text] [Related]
10. A phase II trial of VP-16, ifosfamide, cisplatin, vinblastine, and bleomycin in advanced germ-cell tumors.
Blanke C; Loehrer PJ; Nichols CR; Einhorn LH
Am J Clin Oncol; 1996 Oct; 19(5):487-91. PubMed ID: 8823477
[TBL] [Abstract][Full Text] [Related]
11. Early salvage therapy for germ cell cancer using high dose chemotherapy with autologous bone marrow support.
Broun ER; Nichols CR; Turns M; Williams SD; Loehrer PJ; Roth BJ; Lazarus HM; Einhorn LH
Cancer; 1994 Mar; 73(6):1716-20. PubMed ID: 7512438
[TBL] [Abstract][Full Text] [Related]
12. High-risk germ cell tumors in men. High response rate and severe toxicity with cisplatin, vinblastine, bleomycin, and etoposide.
Blayney DW; Goldberg DA; Leong LA; Margolin KA; Burke JS; Doroshow JH
Cancer; 1993 Apr; 71(7):2351-7. PubMed ID: 7680946
[TBL] [Abstract][Full Text] [Related]
13. A phase II study of high-dose cisplatin, vinblastine, bleomycin, and etoposide (PVeBV regimen) in malignant nondysgerminomatous germ-cell tumors of the ovary.
Culine S; Kattan J; Lhomme C; Duvillard P; Michel G; Castaigne D; Leclere J; Pico J; Droz JP
Gynecol Oncol; 1994 Jul; 54(1):47-53. PubMed ID: 7517380
[TBL] [Abstract][Full Text] [Related]
14. Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council/European Organization for Research and Treatment of Cancer Trial.
Horwich A; Sleijfer DT; Fosså SD; Kaye SB; Oliver RT; Cullen MH; Mead GM; de Wit R; de Mulder PH; Dearnaley DP; Cook PA; Sylvester RJ; Stenning SP
J Clin Oncol; 1997 May; 15(5):1844-52. PubMed ID: 9164194
[TBL] [Abstract][Full Text] [Related]
15. Importance of bleomycin in combination chemotherapy for good-prognosis testicular nonseminoma: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group.
de Wit R; Stoter G; Kaye SB; Sleijfer DT; Jones WG; ten Bokkel Huinink WW; Rea LA; Collette L; Sylvester R
J Clin Oncol; 1997 May; 15(5):1837-43. PubMed ID: 9164193
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum chemotherapy regimen with and without maintenance in patients with resected stage IIB testis cancer.
Vugrin D; Whitmore WF; Herr H; Sogani P; Golbey RB
J Urol; 1982 Oct; 128(4):715-7. PubMed ID: 6183456
[TBL] [Abstract][Full Text] [Related]
17. Reduced platelet survival following chemotherapy with vinblastine, bleomycin and cis-platinum for testicular teratoma.
Rees GJ; Slade RR; Hopes P
Eur J Cancer Clin Oncol; 1982 Nov; 18(11):1125-9. PubMed ID: 6186497
[TBL] [Abstract][Full Text] [Related]
18. Five-year survival of patients with disseminated nonseminomatous testicular cancer treated with cisplatin, vinblastine, and bleomycin.
Stoter G; Vendrik CP; Struyvenberg A; Sleyfer DT; Vriesendorp R; Schraffordt Koops H; van Oosterom AT; ten Bokkel Huinink WW; Pinedo HM
Cancer; 1984 Oct; 54(8):1521-4. PubMed ID: 6206937
[TBL] [Abstract][Full Text] [Related]
19. Paclitaxel+BEP (T-BEP) regimen as induction chemotherapy in poor prognosis patients with nonseminomatous germ cell tumors: a phase II study.
Tryakin A; Fedyanin M; Kanagavel D; Fainstein I; Sergeev J; Polockij B; Matveev V; Zakharova T; Garin A; Tjulandin S
Urology; 2011 Sep; 78(3):620-5. PubMed ID: 21764427
[TBL] [Abstract][Full Text] [Related]
20. Vinblastine, bleomycin and cis-diamminedichloroplatinum in the treatment of advanced testicular carcinoma. Possible importance of longer induction and shorter maintenance schedules.
Bosl GJ; Lange PH; Fraley EE; Nochomovitz LE; Rosai J; Vogelzang NJ; Johnson K; Goldman A; Kennedy BJ
Am J Med; 1980 Apr; 68(4):492-6. PubMed ID: 6154414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]